I-MAK Data

DATASETS

Patent and market data on the bestselling drugs in America.

Summary data used in our 2018 report series Overpatented, Overpriced: How excessive pharmaceutical patenting is extending monopolies and driving up drug prices.

DRUG LIST

The links below refer to the most current data on a specific drug on our website. Older reports are noted in parenthesis.

• Avastin
• Copaxone
• Eliquis
• Enbrel (2018 Special Edition Report)
• Eylea
• Herceptin
• Humira (2018 Special Edition Report)
• Imbruvica
• Keytruda
• Lantus
• Lyrica
• Opdivo
• Remicade
• Revlimid
• Rituxan
• Xarelto